Screener
Harmony Biosciences Holdings, Inc. HRMY Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056720
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Trade payables | $28,600 | $17,693 |
| Accrued compensation | 6,726 | 18,443 |
| Accrued expenses | 150,107 | 191,039 |
| Current portion of long-term debt | 20,000 | 20,000 |
| Other current liabilities | 11,907 | 4,957 |
| Total current liabilities | 217,340 | 252,132 |
| NONCURRENT LIABILITIES: | ||
| Long-term debt, net | 138,814 | 143,663 |
Item 1. Financial Statements
FAQ
- What is Harmony Biosciences Holdings, Inc.'s current debt?
- Harmony Biosciences Holdings, Inc. (HRMY) reported current debt of $20M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s current debt changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s current debt increased by 14.3% year-over-year, from $17.5M to $20M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s current debt?
- Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s current debt has grown at a 77.8% compound annual growth rate (CAGR), from $2M to $20M.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.
Ask your AI about Harmony Biosciences Holdings, Inc.'s current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude